The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 22, Pages 5596
Publisher
MDPI AG
Online
2021-11-09
DOI
10.3390/cancers13225596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature
- (2021) Taira Hada et al. Journal of Ovarian Research
- Rac1, A Potential Target for Tumor Therapy
- (2021) Jiaxin Liang et al. Frontiers in Oncology
- Gastrointestinal-type chemotherapy prolongs survival in an atypical primary ovarian mucinous carcinoma: A case report
- (2021) Qi Wang et al. World Journal of Clinical Cases
- Associations between DNA Damage and PD-L1 Expression in Ovarian Cancer, a Potential Biomarker for Clinical Response
- (2021) Elise K. Mann et al. Biology-Basel
- Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach
- (2021) Chris Vi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic options for mucinous ovarian carcinoma
- (2020) Kylie L. Gorringe et al. GYNECOLOGIC ONCOLOGY
- Ovarian Cancer Targeted Theranostics
- (2020) Sridhar Nimmagadda et al. Frontiers in Oncology
- Efficacy and safety of the antibody-drug conjugate (ADC) SAR408701 in patients (pts) with non-squamous non-small cell lung cancer (NSQ NSCLC) expressing carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5).
- (2020) Anas Gazzah et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation dosimetry of 18F-AzaFol: A first in-human use of a folate receptor PET tracer
- (2020) Silvano Gnesin et al. EJNMMI Research
- Mural nodules in mucinous ovarian tumors represent a morphologic spectrum of clonal neoplasms: a morphologic, immunohistochemical, and molecular analysis of 13 cases
- (2020) David B. Chapel et al. MODERN PATHOLOGY
- CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
- (2020) Katrin Kleinmanns et al. EBioMedicine
- Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
- (2020) Kristen P. Zeligs et al. Frontiers in Oncology
- Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model
- (2020) Patrycja Guzik et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer
- (2020) Diana C. DeLucia et al. CLINICAL CANCER RESEARCH
- The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
- (2020) Katrin Kleinmanns et al. Journal of Personalized Medicine
- Increased NHE1 expression is targeted by specific inhibitor cariporide to sensitize resistant breast cancer cells to doxorubicin in vitro and in vivo
- (2019) Qi Chen et al. BMC CANCER
- An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor
- (2019) Martin Gore et al. GYNECOLOGIC ONCOLOGY
- Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas
- (2019) Hanna Engqvist et al. BMC CANCER
- Recent developments in peptide-based SPECT radiopharmaceuticals for breast tumor targeting
- (2019) Sajjad Ahmadpour et al. LIFE SCIENCES
- The molecular origin and taxonomy of mucinous ovarian carcinoma
- (2019) Dane Cheasley et al. Nature Communications
- Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers?
- (2019) Albertus Wijnand Hensbergen et al. BIOCONJUGATE CHEMISTRY
- MUC16 as a Novel Target for Cancer Therapy
- (2018) Abhijit Aithal et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma
- (2018) Dina Bassiouny et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins
- (2018) Rachel Blau et al. Theranostics
- Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas
- (2018) Massimo Fantini et al. Frontiers in Immunology
- Abstract 1771: BAY 1834942 is an immunotherapeutic antibody blocking the novel immune checkpoint regulator CEACAM6 (CD66c)
- (2018) Joerg Willuda et al. CANCER RESEARCH
- First update on overall survival, progression-free survival, and health-related time-to-deterioration quality of life from the NETTER-1 study: 177Lu-Dotatate vs. high dose octreotide in progressive midgut neuroendocrine tumors.
- (2018) Jonathan R. Strosberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
- (2018) Yang Liu et al. Journal of Hematology & Oncology
- Increased expression of Na+/H+ exchanger isoform 1 predicts tumor aggressiveness and unfavorable prognosis in epithelial ovarian cancer
- (2018) Haixia Wang et al. Oncology Letters
- Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer
- (2018) Hohyeon Lee et al. Theranostics
- When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
- (2018) Carolina Salazar et al. Frontiers in Oncology
- Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
- (2017) Melissa Matz et al. GYNECOLOGIC ONCOLOGY
- Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms
- (2017) Rabab A.A. Mohammed et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression
- (2017) Rui Hou et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma
- (2017) Changhwan Yoon et al. MOLECULAR CANCER RESEARCH
- NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion
- (2017) Rui Xie et al. ONCOLOGY REPORTS
- Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy
- (2017) Mengjiao Li et al. Journal of Ovarian Research
- Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model
- (2017) Muhammad Ikram et al. Oncotarget
- Mucinous epithelial ovarian carcinoma
- (2016) T. J. Perren ANNALS OF ONCOLOGY
- Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer
- (2016) Isabel Rauscher et al. CLINICAL NUCLEAR MEDICINE
- Mucinous ovarian cancer: A therapeutic review
- (2016) Wen Xu et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
- (2016) Marlon Perera et al. EUROPEAN UROLOGY
- HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer
- (2016) Gaofeng Fan et al. GENES & DEVELOPMENT
- PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
- (2016) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis
- (2015) Y.R. Huo et al. EJSO
- PTPRN2 and PLC 1 promote metastatic breast cancer cell migration through PI(4,5)P2-dependent actin remodeling
- (2015) C. A. Sengelaub et al. EMBO JOURNAL
- Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
- (2015) Tobias Maurer et al. EUROPEAN UROLOGY
- Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
- (2015) Devansu Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome
- (2015) Ruobing Leng et al. MEDICAL ONCOLOGY
- Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging
- (2015) Levent Kabasakal et al. NUCLEAR MEDICINE COMMUNICATIONS
- EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy
- (2015) Srinivas Ganta et al. PHARMACEUTICAL RESEARCH
- The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors
- (2015) Varvara Vitiazeva et al. PLoS One
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Assessing the HER2 Status in Mucinous Epithelial Ovarian Cancer on the Basis of the 2013 ASCO/CAP Guideline Update
- (2014) Wan-Ru Chao et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- 68Gallium- and 90Yttrium-/177Lutetium: “theranostic twins” for diagnosis and treatment of NETs
- (2014) Rudolf A. Werner et al. ANNALS OF NUCLEAR MEDICINE
- Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
- (2014) J. Spiliotis et al. ANNALS OF SURGICAL ONCOLOGY
- HER2 Expression in Ovarian Mucinous Carcinomas in Tunisia
- (2014) Nabiha Missaoui et al. Asian Pacific Journal of Cancer Prevention
- Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells
- (2014) S. W. Hofbauer et al. BLOOD
- Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
- (2014) M Köbel et al. BRITISH JOURNAL OF CANCER
- RAC1 inhibition as a therapeutic target for gefitinib-resistant non-small-cell lung cancer
- (2014) Naoki Kaneto et al. CANCER SCIENCE
- Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours
- (2014) Jayson Wang et al. HISTOPATHOLOGY
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma
- (2014) Jonathan A. Ledermann et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- A Qualitative Study Comparing the Assay Performance Characteristics Between the 2007 and the 2013 American Society for Clinical Oncology and College of American Pathologists HER2 Scoring Methods in Mucinous Epithelial Ovarian Cancer
- (2014) Chi-Kuan Chen et al. MEDICINE
- Theranostic applications of antibodies in oncology
- (2014) Emmy D.G. Fleuren et al. Molecular Oncology
- Development of EGFR-Targeted Nanoemulsion for Imaging and Novel Platinum Therapy of Ovarian Cancer
- (2014) Srinivas Ganta et al. PHARMACEUTICAL RESEARCH
- CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas
- (2014) Ok-Jun Lee et al. VIRCHOWS ARCHIV
- Targeted Radionuclide Therapy with A 177Lu-labeled Anti-HER2 Nanobody
- (2014) Matthias D'Huyvetter et al. Theranostics
- The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
- (2013) Junli Deng et al. CANCER AND METASTASIS REVIEWS
- Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: A pilot study
- (2013) Peter A. Argenta et al. GYNECOLOGIC ONCOLOGY
- Expression of Folate Receptor-α (FRA) in Gynecologic Malignancies and its Relationship to the Tumor Type
- (2013) Daniel J. O’Shannessy et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
- (2013) Taku Okazaki et al. NATURE IMMUNOLOGY
- GPR158, an Orphan Member of G Protein-Coupled Receptor Family C: Glucocorticoid-Stimulated Expression and Novel Nuclear Role
- (2013) Nitin Patel et al. PLoS One
- Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations
- (2012) S. M. Hunter et al. CLINICAL CANCER RESEARCH
- NHE-1: A Promising Target for Novel Anti-cancer Therapeutics
- (2012) Ser Yue Loo et al. CURRENT PHARMACEUTICAL DESIGN
- Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
- (2012) Michael S Anglesio et al. JOURNAL OF PATHOLOGY
- Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
- (2012) Terrence Chua et al. Cancer Management and Research
- Natural history and outcome of mucinous carcinoma of the ovary
- (2011) Maria B. Schiavone et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer
- (2011) Yoshimichi Tanaka et al. CANCER BIOLOGY & THERAPY
- Role of Rho GTPases and their regulators in cancer progression
- (2011) Rajamani Rathinam Frontiers in Bioscience-Landmark
- Mucinous tumours of the ovary
- (2011) Jay D Naik et al. JOURNAL OF CLINICAL PATHOLOGY
- Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumours
- (2011) B. Yan et al. JOURNAL OF CLINICAL PATHOLOGY
- Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics
- (2011) Yuan Tian et al. PROTEOMICS
- HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population
- (2011) Pamela L. Kunz et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase–9 in ovarian epithelial cancer and relation to patient deaths
- (2010) Hanan AlSaeid Alshenawy Annals of Diagnostic Pathology
- Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience
- (2010) J. Alexandre et al. ANNALS OF ONCOLOGY
- Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer
- (2010) Li Wang et al. CANCER LETTERS
- Expression of aberrantly glycosylated Mucin-1 in ovarian cancer
- (2010) Catharina H M J Van Elssen et al. HISTOPATHOLOGY
- Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
- (2010) Helen J. Mackay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Expression of octamer-4 in serous and mucinous ovarian carcinoma
- (2010) J. Zhang et al. JOURNAL OF CLINICAL PATHOLOGY
- HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
- (2009) Jessica N McAlpine et al. BMC CANCER
- Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells
- (2009) Beatrix Hage et al. Cell Communication and Signaling
- Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer
- (2009) Liangdan Tang et al. EUROPEAN JOURNAL OF CANCER
- Clinicopathological characteristics of mucinous adenocarcinoma of the ovary
- (2009) Muneaki Shimada et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More